A Phase I/II Trial of the combination of BRAF and EGFR inhibition in BRAF V600E mutant metastatic colorectal, advanced or metastatic lung adenocarcinoma and other cancers

  • Markman, Ben (Primary Chief Investigator (PCI))

Project: Research

Project Details

Project Description

SERP Reference Number: HREC/13/MH/446.
SSA Reference Number: SSA/15/MonH/17
Monash Health HREC Ref: 15054X
Effective start/end date20/12/1819/12/23